AHA GUIDELINES Bundle (free trial)

Atrial Fibrillation 2023 Update

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/387790

Contents of this Issue

Navigation

Page 22 of 131

23 Table 4. Definitions Term Definition Atrial fibrillation A supraventricular tachyarrhythmia with uncoordinated atrial activation and ineffective atrial contraction ECG characteristics include (a) irregular R-R intervals (when atrioventricular [AV] conduction is present), (b) absence of distinct P waves, and (c) irregular atrial activity also known as fibrillatory waves. AF can be documented by 12 lead ECG, rhythm strips, wearables, intracardiac electrograms, etc. but will always require visual confirmation that the diagnosis is accurate. Clinical AF With the increasing availability of wearable devices and other continuous monitoring technologies, the distinction between clinical and subclinical AF has become increasingly blurred thus the writing group felt the term clinical AF has become less useful. Yet, the term was kept since most of the evidence from randomized trials that have led to guideline recommendations for the treatment of AF refer to "clinical AF." ese trials required ECG documentation of the arrhythmia for inclusion and a majority of patients presented for clinical evaluation and/or therapy of the arrhythmia. Subclinical AF Subclinical AF refers to this arrhythmia identified in individuals who do not have symptoms attributable to AF and in whom there are no prior ECGs documenting AF. is includes AF identified by implanted devices (pacemakers, defibrillators, or implantable loop recorders) or wearable monitors. Atrial high-rate episodes (AHRE) ese are defined as atrial events exceeding the programmed detection rate limit set by the device. ese are recorded by implanted devices but require visual inspection to confirm AF and exclude other atrial arrhythmias, artifact or oversensing. AF burden AF burden encompasses both frequency and duration and refers to the amount of AF that an individual has. AF burden has been defined differently across studies. For the purpose of this guideline, AF burden will be defined as the durations of an episode or as a percentage of AF duration during the monitoring period depending on how it was defined in the individual studies. First detected AF The first documentation of AF, regardless of prior symptoms Paroxysmal AF AF that is intermittent and terminates within ≤7 days of onset Persistent AF AF that is continuous and sustains for >7 days and requires intervention. Of note, patients with persistent AF who with therapy become paroxysmal should still be defined as persistent as this reflects their original pattern and is a more useful to predict outcomes and define substrate.

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Atrial Fibrillation 2023 Update